Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Curis raises $47 million in financing:

This article was originally published in Clinica

Executive Summary

Tissue regeneration company Curis has raised nearly $47 million in a private financing. The company is expecting multiple regulatory, clinical and manufacturing milestones early this year and says the fresh funds put it in a strong position to capitalise on these. Nearest to market is OP-1, a product for non-union fractures, which was developed with Stryker and is under regulatory review in the US, Europe and Australia. Curis, based in Cambridge, Massachusetts, is the result of a merger between Creative BioMolecules, Ontogeny and Reprogenesis (see Clinica No 908, p 14).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069472

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel